Patents by Inventor Hiroya TAKIZAWA

Hiroya TAKIZAWA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dihydronaphthalene derivative
    Patent number: 11471436
    Abstract: A compound represented by general formula (I) wherein all the symbols are as defined in the specification has a selective S1P5 receptor agonist activity due to having a linker from a phenyl group to a cyclic substituent in a dihydronaphthalene skeleton; i.e., due to having a short linker of one atom or less as L in general formula (I), and can therefore serve as an agent for treating S1P5-mediated disease, e. g., neurodegenerative disease such as schizophrenia.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: October 18, 2022
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kensuke Kusumi, Haruto Kurata, Atsushi Naganawa, Yasuyo Kodera, Yuichi Inagaki, Hiroya Takizawa, Mark Allan Wolf, Joseph Raker
  • DIHYDRONAPHTHALENE DERIVATIVE
    Publication number: 20170327439
    Abstract: A compound represented by general formula (I) (wherein, all the symbols are as defined in the specification) has a selective S1P5 receptor agonist activity due to having a linker from a phenyl group to a cyclic substituent in a dihydronaphthalene skeleton; .i.e., due to having a short linker of one atom or less as L in general formula (I), and can therefore serve as an agent for treating S1P5-mediated disease, e.g., neurodegenerative disease such as schizophrenia.
    Type: Application
    Filed: December 3, 2014
    Publication date: November 16, 2017
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kensuke KUSUMI, Haruto KURATA, Atsushi NAGANAWA, Yasuyo KODERA, Yuichi INAGAKI, Hiroya TAKIZAWA, Mark Allan WOLF, Joseph RAKER